Electronic cigarette use intensity measurement challenges and regulatory implications.
addiction
electronic nicotine delivery devices
non-cigarette tobacco products
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
13
01
2021
revised:
19
04
2021
accepted:
20
04
2021
pubmed:
2
6
2021
medline:
20
12
2022
entrez:
1
6
2021
Statut:
ppublish
Résumé
Assessing tobacco use intensity allows researchers to examine tobacco use in greater detail than assessing ever or current use only. Tobacco use intensity measures have been developed that are specific to tobacco products, such as asking smokers to report number of cigarettes smoked per day. However, consensus on electronic cigarette use intensity measures that can be used for survey research has yet to be established due to electronic cigarette product and user behavior heterogeneity. While some survey measures that attempt to assess electronic cigarette use intensity exist, such as examining number of 'times' using an electronic cigarette per day, number of puffs taken from an electronic cigarette per day, volume of electronic cigarette liquid consumed per day, or nicotine concentration of electronic cigarette liquid, most measures have limitations. Challenges in electronic cigarette measurement often stem from variations across electronic cigarette device and liquid characteristics as well as the difficulty that many electronic cigarette users have regarding answering questions about their electronic cigarette device, liquid, or behavior. The inability for researchers to measure electronic cigarette use intensity accurately has important implications such as failing to detect unintended consequences of regulatory policies. Development of electronic cigarette use intensity measures, though not without its challenges, can improve understanding of electronic cigarette use behaviors and associated health outcomes and inform development of regulatory policies.
Identifiants
pubmed: 34059553
pii: tobaccocontrol-2021-056483
doi: 10.1136/tobaccocontrol-2021-056483
pmc: PMC8630087
mid: NIHMS1720133
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Research Support, U.S. Gov't, P.H.S.
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
124-129Subventions
Organisme : NCI NIH HHS
ID : U54 CA228110
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA036105
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 DA999999
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA046060
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA180905
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: ES is named on a patent application for a smartphone app that determines electronic cigarette device and liquid characteristics.
Références
Tob Control. 2021 May;30(3):348-350
pubmed: 32522818
Nicotine Tob Res. 2019 Aug 19;21(9):1206-1212
pubmed: 29982710
Drug Alcohol Depend. 2018 Jul 1;188:193-199
pubmed: 29778773
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164
pubmed: 30763302
JAMA Intern Med. 2017 Jan 1;177(1):87-95
pubmed: 27918784
Ann Agric Environ Med. 2016 Jul 15;23(3):395-8
pubmed: 27660856
Nicotine Tob Res. 2016 May;18(5):720-3
pubmed: 26377515
Tob Control. 2016 Apr;25(e1):e6-9
pubmed: 26324250
Ann N Y Acad Sci. 2017 Apr;1394(1):5-30
pubmed: 26774031
Tob Control. 1998 Winter;7(4):369-75
pubmed: 10093170
Addict Res Theory. 2016;24(1):80-88
pubmed: 29176939
MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1209-1215
pubmed: 29121001
Nicotine Tob Res. 2006 Aug;8(4):575-80
pubmed: 16920655
MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):597-603
pubmed: 28617771
MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):381-5
pubmed: 25879896
Exp Clin Psychopharmacol. 2020 Oct;28(5):527-539
pubmed: 31855003
Tob Control. 2021 Mar;30(2):234-235
pubmed: 32184338
J Addict Med. 2018 Mar/Apr;12(2):127-131
pubmed: 29280749
Curr Neuropharmacol. 2018;16(4):438-459
pubmed: 29046158
Sci Rep. 2020 Apr 30;10(1):7322
pubmed: 32355323
Tob Control. 2019 Nov;28(6):678-680
pubmed: 30745326
Drug Alcohol Depend. 2017 Oct 1;179:337-340
pubmed: 28843084
Drug Alcohol Depend. 2019 Nov 1;204:107512
pubmed: 31487572
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019
pubmed: 31725711
Nicotine Tob Res. 2020 Apr 21;22(5):699-704
pubmed: 30365024
MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):542-7
pubmed: 24964880
Nicotine Tob Res. 2020 Oct 29;22(11):2123
pubmed: 31254382
Addict Behav. 2018 Apr;79:93-101
pubmed: 29272713
Addict Behav. 2018 Apr;79:203-212
pubmed: 29173942
Nicotine Tob Res. 2018 Jul 9;20(8):998-1003
pubmed: 29065196
Exp Clin Psychopharmacol. 2017 Oct;25(5):380-392
pubmed: 29048187
Nicotine Tob Res. 2015 Feb;17(2):150-7
pubmed: 25187061
Nicotine Tob Res. 2018 Jan 5;20(2):215-223
pubmed: 27798087
MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7
pubmed: 27077789
JAMA. 2019 Dec 3;322(21):2095-2103
pubmed: 31688912
Int J Clin Pract. 2014 Nov;68(11):1358-63
pubmed: 25113663
JAMA Netw Open. 2020 Jun 1;3(6):e206436
pubmed: 32492162
Tob Control. 2017 Mar;26(e1):e23-e28
pubmed: 27729564
Nicotine Tob Res. 2015 Feb;17(2):186-92
pubmed: 25332459
Addiction. 2019 May;114(5):896-906
pubmed: 30644627
Nicotine Tob Res. 2017 Feb;19(2):190-196
pubmed: 27613944
Nat Rev Cardiol. 2017 Aug;14(8):447-456
pubmed: 28332500
Aerosol Sci Technol. 2017;51(1):1-11
pubmed: 28706340
Nicotine Tob Res. 2014 Dec;16(12):1620-8
pubmed: 25063772
Tob Regul Sci. 2016 Oct;2(4):426-439
pubmed: 28819633
MMWR Morb Mortal Wkly Rep. 2018 Nov 09;67(44):1225-1232
pubmed: 30408019
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
JAMA. 2019 Nov 12;322(18):1824-1827
pubmed: 31524940
Drug Test Anal. 2021 Feb;13(2):242-260
pubmed: 33450135
Addiction. 2018 Oct;113(10):1874-1882
pubmed: 29882257